- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Vinflunine
Total 33 results
-
Veeda OncologyBristol-Myers SquibbCompletedNon-Small Cell Lung CancerUnited States
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedLung Cancer | Carcinoma, Small CellUnited States
-
Institute of Cancer Research, United KingdomSt George's Healthcare NHS TrustCompletedLocally-advanced or Metastatic Penile NeoplasmsUnited Kingdom
-
Associació per a la Recerca Oncologica, SpainUnknownUrothelium Transitional Cell CarcinomaSpain, Netherlands
-
Bristol-Myers SquibbTerminatedStomach CancerKorea, Republic of, Philippines, Malaysia
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompleted
-
Bristol-Myers SquibbPierre Fabre MedicamentCompletedKidney Neoplasms | Transitional Cell Carcinoma | Bladder Cancer | Bladder Neoplasms | Ureter Neoplasms | Neoplasm, BladderUnited States, Spain, Italy, Canada, Indonesia, Singapore, Australia, Austria, France, Greece, Korea, Republic of, Philippines, Sweden, Switzerland, Thailand
-
Bristol-Myers SquibbCompleted
-
Pierre Fabre MedicamentBristol-Myers SquibbCompletedBladder Cancer | Bladder Neoplasms | Transitional Cell Carcinoma of the Urothelial TractCanada
-
Ligartis GmbHWithdrawn
-
Spanish Oncology Genito-Urinary GroupCompletedCarcinoma, Transitional CellSpain
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedBreast Cancer | Breast NeoplasmsUnited States
-
UNC Lineberger Comprehensive Cancer CenterBristol-Myers SquibbTerminated
-
Prof. Dr. Thomas OttoCompletedAdvanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy.Germany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Withdrawn
-
Pierre Fabre MedicamentCompletedBladder Transitional Cell Carcinoma Stage IVFrance
-
Dr Anders UllénBayer; Pierre Fabre Laboratories; Nordic Urothelial Cancer Oncology GroupCompletedBladder Cancer | Urothelial Carcinoma | Urethra Cancer | Ureter Cancer | Renal Pelvis CancerDenmark, Sweden
-
Pierre Fabre MedicamentCompletedBreast CancerFrance, Poland, Ukraine, United Kingdom, Taiwan, Spain, Belgium, Belarus, Mexico, Bulgaria, India, South Africa, Brazil, Russian Federation, Argentina, Hungary, Italy, Serbia, Switzerland, Czechia, Estonia
-
Pierre Fabre MedicamentCompletedMalignant Neoplasm of BreastChina, Taiwan, Singapore
-
Pierre Fabre MedicamentCompletedBreast Cancer | MetastasesFrance, Ukraine, United Kingdom, Germany, Taiwan, Spain, Belarus, Belgium, Portugal, South Africa, Russian Federation, Austria, Italy, Argentina
-
Astellas Pharma Global Development, Inc.Seagen Inc.Active, not recruitingBladder Cancer | Urothelial Cancer | Ureteral CancerUnited States, Japan, Korea, Republic of, Taiwan, Argentina, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Portugal, Russian Federation, Spain, Switzerland, United Kingdom
-
Bristol-Myers SquibbCompletedTransitional Cell Carcinoma | Bladder Cancer | MetastasisUnited States, Korea, Republic of, United Kingdom, Spain, Australia, France, Thailand, Denmark, Poland, Belgium, Italy, Philippines, Canada, Russian Federation, Greece, Indonesia
-
Merck Sharp & Dohme LLCCompleted
-
Dr Anders UllénCompletedBladder Cancer | Urothelial Carcinoma | Urethra Cancer | Ureter Cancer | Renal Pelvis CancerDenmark, Sweden
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CancerKorea, Republic of, United States, Italy, Spain, Japan, United Kingdom, Belgium, Israel, China, Austria, France, Canada, Taiwan, Turkey, Germany, Russian Federation, Bulgaria, Poland, Greece, Brazil, Netherlands, Australia, Argentina, Mexic... and more
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
Pierre Fabre MedicamentTerminated
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
-
Bristol-Myers SquibbCompleted
-
Pierre Fabre MedicamentCompletedRecurrent or Metastatic Head and Neck CarcinomaFrance
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Bristol-Myers SquibbWithdrawn
-
Federal University of Minas GeraisCompletedLeukemia | Non Hodgkin LymphomaBrazil